- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-1-1-1-mer
- Ligands
- 2 x 7V7: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide(Non-covalent)
- 10 x CLR: CHOLESTEROL(Non-covalent)
CLR.2: 7 residues within 4Å:- Chain A: M.100, N.110, L.113, L.117, Y.150, K.186, W.193
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.113, A:L.117
CLR.3: 5 residues within 4Å:- Chain A: T.295, P.296, Y.300, I.303, S.318
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:T.295, A:P.296, A:P.296, A:Y.300, A:Y.300, A:I.303
CLR.4: 12 residues within 4Å:- Chain A: L.195, A.198, I.199, P.202, M.206, W.229, L.233, C.236, F.240
- Chain F: L.195, F.240
- Ligands: CLR.11
10 PLIP interactions:8 interactions with chain A, 2 interactions with chain F- Hydrophobic interactions: A:L.195, A:A.198, A:I.199, A:I.199, A:P.202, A:W.229, A:L.233, A:F.240, F:L.195, F:F.240
CLR.5: 7 residues within 4Å:- Chain A: W.227, Y.228, N.231
- Chain F: V.164, H.172, K.175
- Ligands: CLR.8
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain F- Hydrophobic interactions: A:W.227, A:Y.228, A:N.231, F:V.164
CLR.6: 7 residues within 4Å:- Chain A: Y.167, L.247, V.251
- Chain F: I.235, I.239, L.306
- Ligands: CLR.12
6 PLIP interactions:3 interactions with chain F, 3 interactions with chain A- Hydrophobic interactions: F:I.235, F:I.239, F:I.239, A:L.247, A:V.251, A:V.251
CLR.8: 9 residues within 4Å:- Chain A: I.235, I.239, L.306
- Chain F: Y.167, M.244, L.247, V.251, L.255
- Ligands: CLR.5
6 PLIP interactions:4 interactions with chain F, 2 interactions with chain A- Hydrophobic interactions: F:L.247, F:V.251, F:V.251, F:L.255, A:I.235, A:I.239
CLR.9: 8 residues within 4Å:- Chain F: M.100, I.106, F.109, N.110, L.113, L.117, K.186, W.193
8 PLIP interactions:8 interactions with chain F- Hydrophobic interactions: F:I.106, F:F.109, F:L.113, F:L.117, F:K.186, F:W.193, F:W.193
- Hydrogen bonds: F:K.186
CLR.10: 4 residues within 4Å:- Chain F: P.296, Y.300, I.303, S.318
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:P.296, F:Y.300, F:Y.300, F:I.303
CLR.11: 10 residues within 4Å:- Chain F: F.157, L.195, A.198, I.199, M.206, W.229, L.233, C.236, F.240
- Ligands: CLR.4
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:F.157, F:L.195, F:I.199, F:I.199, F:W.229, F:L.233, F:F.240
CLR.12: 9 residues within 4Å:- Chain A: V.164, H.172, K.175, I.248
- Chain F: W.227, Y.228, N.231, I.235
- Ligands: CLR.6
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain F- Hydrophobic interactions: A:V.164, A:I.248, F:W.227, F:Y.228, F:N.231, F:I.235
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhuang, Y. et al., Molecular recognition of morphine and fentanyl by the human mu-opioid receptor. Cell (2022)
- Release Date
- 2022-11-09
- Peptides
- Mu-type opioid receptor: AF
Guanine nucleotide-binding protein G(i) subunit alpha-1: BG
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1: C
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2: D
scFv16: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
RF
MB
AG
FC
BD
CE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-1-1-1-mer
- Ligands
- 2 x 7V7: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide(Non-covalent)
- 10 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhuang, Y. et al., Molecular recognition of morphine and fentanyl by the human mu-opioid receptor. Cell (2022)
- Release Date
- 2022-11-09
- Peptides
- Mu-type opioid receptor: AF
Guanine nucleotide-binding protein G(i) subunit alpha-1: BG
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1: C
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2: D
scFv16: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
RF
MB
AG
FC
BD
CE
E - Membrane
-
We predict this structure to be a membrane protein.